Viridian Chart Of The Week

Beyond Amazon And Coca-Cola: Why Cannabis Is Catching Up To Blue Chip Stocks In Profitability
Cannabis Chart Of The Week: How Much Are U.S. MSOs Undervalued Compared To Other Industries?
Cannabis Chart Of The Week: How Much Have MSO Valuation Multiples Changed In The Last Year And Why?
Cannabis Chart Of The Week: How Much Are U.S. MSOs Undervalued Compared To Other Industries?
Cannabis Chart Of The Week: How Much Have MSO Valuation Multiples Changed In The Last Year And Why?
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
Viridian Chart Of The Week: Is Consolidation Increasing In Cannabis?

Viridian Chart Of The Week Recent News

Cannabis Chart Of The Week: Who's Growing In Florida, And Has The State Gotten Ahead Of Itself?
Florida is often considered one of the most critical states in terms of growing legal cannabis sales. The State is estimated to have approximately $2.6B in 2023 legal sales, representing a per capita consumption of about $118 based on the total population or $145 based on adult population.
Five Stocks That Are Attractively Priced, Solid Credits, With Room To Run
The first week of 2024 saw significant stock price appreciation for most of the 30 stocks Viridian Capital Advisors credit ranks weekly. As a proxy, the MSOS ETV rose 12.84%, the sharpest uptick since the HHS announcement at the end of August. There was no particular news to account for the uptick except for confirmation from the DEA that they are indeed studying the issue of rescheduling.
Cannabis Chart Of The Week: Where Are Sector Leaders Trading Relative To Their 52-Week Highs And Lows?
This week’s Viridian Chart of the Week looks at the stock prices of the leaders in several cannabis sectors, including Agriculture Technology, Cultivation and Retail, Psychedelics, and Financial Services, relative to their 52-week highs and lows. The chart is arranged in increasing order of trading prices relative to 52-week lows within each sector.
Cannabis Chart Of The Week: Who Are The Strongest MSO Credits And How Are They Trending?
The Viridian Credit Tracker model is a valuable tool for investors and companies alike to gauge the credit quality of cannabis companies. The model utilizes 11 market-based and financial statement-based variables to measure four critical attributes of credit quality: Liquidity, Leverage, Profitability, and Size.
Cannabis Chart Of The Week: Which Companies Have The Most Upside And Downside From A DEA Announcement?
The MSOS ETF is now up 41.4% from the August 30, 2023, HHS rescheduling announcement, but it has fallen significantly from its peak gain of 85.0% in mid-September. The Viridian Chart of the Week looks at the potential upside and downside of the top 15 MSOs concerning a DEA announcement on rescheduling.
Viridian Chart Of The Week: New Adult Rec States Are Likely To Drive Significant Cannabis Sales Growth
2023 has been a disappointing year for cannabis, and according to consensus estimates, the top ten MSOs will have a 2023 revenue growth of only 1% and an EBITDA decline of 1% compared to 2022.
Viridian Chart Of The Week: Finding The Right Balance Between Cheapness And Safety In Cannabis Stocks
Third-quarter earnings have been released for all companies in the Viridian Chart of the Week. Equity prices have had an opportunity to react to the news (or not). 
Cannabis Chart Of The Week: Revenue And EBITDA Beats Are Great, But The Real Story Is Cash Flow From Operations
Third-quarter earnings releases still have about a week to go. Still, eight companies representing over 78% of the total market cap of the fourteen MSOs with market caps over $100M have reported and appear in the graph below. 
Cannabis Chart Of The Week: Why Did Stocks Perform So Differently In The Capitulation Last Week?
How can we explain the cataclysmic capitulation in cannabis stock prices last week, with the MSOS ETF down 21.5%? Was it just a reaction to a less cannabis-friendly Speaker of the House? The timing of the decline, beginning in earnest on October 25, does seem to lend some credence to this view. 
Cannabis Chart Of The Week: Most MSO Revenue Growth Is New Market Related
The Viridian Chart of the Week shows analyst estimates for MSO revenue for the third quarter of 2023 relative to the second quarter of 2023 and the third quarter of 2022. The green bars depict estimated sequential quarter growth for Q3:23, while the orange bars show year-over-year growth.
Viridian Chart Of The Week: A Valuable Investor Tool To Track Cannabis Credit Quality
Monitoring the credit quality of portfolio companies has become critical in the capital-starved environment of 2023, and, in fact, credit analysis has become the new equity analysis. Credit quality is multidimensional by nature: The Viridian Credit Tracker Model uses 11 market and financial variables to quantify four main credit factors: Liquidity, Leverage, Profitability, and Size, each o
Cannabis Chart Of The Week: Will Debt Maturities Trip Up The MSOs?
Nine of the ten largest debt raises ever completed for U.S. Cultivation & Retail companies were closed in 2021 and 2022. Over $4.3B of debt was sold over this period, far more than in any similar period in U.S. Cannabis history. Debt became the largest source of capital to the industry in 2022, and its percentage of total capital raised has increased further in 2023 YTD.
Cannabis Chart Of The Week: Who Has The Strongest Working Capital Position?
The fourteen MSOs in the graph have all worked hard over the last year to lean down their working capital usage in order to increase operating cash flow.
Cannabis Chart Of The Week: Q2 EBITDAs Beat Estimates, But Full-Year Projections Tell A Different Story
Second quarter 2023 earnings releases are complete, and the results were fascinating. One of the things that makes us skeptical about these quarterly reports is the forceful steering that companies apply to try to move estimates down.
Cannabis Chart Of The Week: What SHOULD EBITDA Multiples Be?
We created a discounted cash flow model ("DCF") to calculate a range of theoretically supportable EV/EBITDA multiples, given analysts' expectations for 2022-2024 and reasonable assumptions for the seven years after that.
Viridian Chart Of The Week: Are There Opportunities For Investors In Cannabis Debt?
The chart shows Viridian Capital Advisors Credit Tracker rankings of credit quality for nineteen public U.S. cannabis companies with market caps over $25M, along with the offered-side trading yield of the company’s debt (blue squares) or the effective cost at the closing of the company’s 2023 debt issue (orange triangle).
Cannabis Chart of the Week: How Aggressive Are 2nd Quarter EBITDA Margin Estimates?
The chart shows analyst estimates of EBITDA margins for the second quarter vs. the first quarter and the 2nd quarter of 2022 for the fourteen largest MSOs for which we have consistent analyst projections.
Cannabis Chart Of The Week: Are There Good Values Among Canadian Cannabis Companies?
This week's chart explores the valuation and credit of the eighteen U.S. and Canadian cannabis companies with market caps between $20M and $100M. The presence of U.S. and Canadian companies in the group allows for comparing credit quality and valuation.
Cannabis Chart Of The Week: Debt Raises Decline As Effective Cost Of Capital Increases
This week's chart explores the relationship between U.S. Cultivation & Retail sector debt issuance and effective costs of debt.
What's The Real Value Of Smaller And Under-Covered Cannabis Stocks?
The chart explores the relative credit quality and valuation of the eight public U.S. cannabis companies with market caps over $20M and coverage from fewer than two sell-side analysts.
Cannabis Chart Of The Week: Rule 280e – Taxation Without Representation?
In honor of Independence Day, the Viridian Capital Chart of the Week explores the impact of IRS Rule 280e, the most egregious tax leveled on any American industry, posing an existential threat to even some of the largest MSOs.
Cannabis Chart Of The Week: What's The Right Way To Measure MSO Leverage?
The credit quality of cannabis companies has taken center stage in 2023 as the equity capital markets remain shuttered and growth and operating profits remain constrained.
What Are The Cheapest Cannabis Stocks That Are Safe To Own?
Cannabis Cultivation and Retail sector stocks are historically cheap; however, many carry a financial risk that is too high for all but the most intrepid investors.